Trial intelligence / Profile preview

Volumetric Analysis of Parotid Gland after Botox Injection

KCT0003075Phase 4Not yet recruiting

Sponsor
Hugel
Start
Sep 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in hypersalivation, sponsored by Hugel. Planned start Sep 2018; status: not yet recruiting.

02

Drugs

botulinum toxin type A
03

Conditions

hypersalivation

Beyond the preview

Go deeper on KCT0003075.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003075.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call